Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06995534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Splinting vs Exercise in De Quervain's Tenosynovitis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 24, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Aug 1, 2024 to May 29, 2025
    • Primary completion date: Apr 30, 2026 to Apr 1, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence. The aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional/symptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and patient satisfaction.
Trial Details
NCT Number NCT06995534
Lead Sponsor Konya Beyhekim Training and Research Hospital
Conditions
(from sponsor)		 Splints, Exercise Therapy, De Quervains Tenosynovitis, Pain Management, Ultrasonographic
Related terms Agnosia, De Quervain Disease, Pain
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov